Inhibition of the hepatocarcinogenicity of aflatoxin B1 in rats by low levels of the phenolic antioxidants butylated hydroxyanisole and butylated hydroxytoluene.

Williams, G M; Iatropoulos, M J

Williams, G M; Iatropoulos, M J.

Affiliation

Williams GM; American Health Foundation, Valhalla, NY 10595, USA.

Cancer Lett ; 104(1): 49-53, 1996 Jun 24.

Article in En | MEDLINE | ID: mdl-8640745

Subject(s)

Aflatoxin B1/antagonists & inhibitors; Anticarcinogenic Agents/therapeutic use; Antioxidants/therapeutic use; Butylated Hydroxyanisole/therapeutic use; Butylated Hydroxytoluene/therapeutic use; Carcinogens; Liver Neoplasms, Experimental/chemically induced; Liver Neoplasms, Experimental/prevention & control; Animals; Body Weight/drug effects; Dose-Response Relationship, Drug; Food Contamination; Liver/anatomy & histology; Liver/drug effects; Male; Organ Size/drug effects; Rats; Rats, Inbred F344

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Butylated Hydroxyanisole / Butylated Hydroxytoluene / Carcinogens / Anticarcinogenic Agents / Aflatoxin B1 / Liver Neoplasms, Experimental / Antioxidants Limits: Animals Language: En Journal: Cancer Lett Year: 1996 Document type: Article Affiliation country: United States Country of publication: Ireland

Search on Google

Add to My VHL

XML

PubMed Links